ALLIGENT BIOPHARM CONSULTING (EUROPE) LIMITED

Company number 10138701

Date	Type	Description	View / Download
12 Jul 2019	GUARANTEE2	Audit exemption statement of guarantee by parent company for period ending 31/12/18	(3 pages)
21 Jun 2019	SH01	Statement of capital following an allotment of shares on 29 May 2019 USD 262,766,211.54	(4 pages)
01 May 2019	CS01	Confirmation statement made on 20 April 2019 with no updates	(3 pages)
13 Dec 2018	AP01	Appointment of Mr Benjamin Maurice Frederick Witcher as a director on 26 November 2018	(2 pages)
13 Dec 2018	TM01	Termination of appointment of Simon William Lyall-Cottle as a director on 26 November 2018	(1 page)
05 Oct 2018	AA	Audit exemption subsidiary accounts made up to 31 December 2017	(18 pages)
05 Oct 2018	PARENT_ACC	Consolidated accounts of parent company for subsidiary company period ending 31/12/17	(49 pages)
24 Sep 2018	AGREEMENT2	Notice of agreement to exemption from audit of accounts for period ending 31/12/17	(1 page)
24 Sep 2018	GUARANTEE2	Audit exemption statement of guarantee by parent company for period ending 31/12/17	(3 pages)
15 May 2018	CS01	Confirmation statement made on 20 April 2018 with no updates	(3 pages)
10 Oct 2017	AA	Audit exemption subsidiary accounts made up to 31 December 2016	(12 pages)
10 Oct 2017	PARENT_ACC	Consolidated accounts of parent company for subsidiary company period ending 31/12/16	(41 pages)
10 Oct 2017	GUARANTEE2	Audit exemption statement of guarantee by parent company for period ending 31/12/16	(3 pages)
10 Oct 2017	AGREEMENT2	Notice of agreement to exemption from audit of accounts for period ending 31/12/16	(1 page)
04 May 2017	CS01	Confirmation statement made on 20 April 2017 with updates	(6 pages)
27 Apr 2017	AD03	Register(s) moved to registered inspection location Belmont House Station Way Crawley RH10 1JA	(1 page)
27 Apr 2017	AD02	Register inspection address has been changed to Belmont House Station Way Crawley RH10 1JA	(1 page)
02 Mar 2017	CH01	Director's details changed for John David Gille on 6 July 2016	(2 pages)
02 Mar 2017	RESOLUTIONS	Resolutions NM01 ‐ Change of name by resolution RES15 ‐ Change company name resolution on 2017-02-02	(3 pages)
13 Sep 2016	SH01	Statement of capital following an allotment of shares on 6 July 2016 USD 116,299,244.37	(4 pages)
20 Jul 2016	AP01	Appointment of John David Gille as a director on 6 July 2016	(3 pages)
20 Jul 2016	AD01	Registered office address changed from 1 Grafton Street London W1S 4FE United Kingdom to Envision House 5 North Street Horsham West Sussex RH12 1XQ on 20 July 2016	(2 pages)
05 Jul 2016	MR01	Registration of charge 101387010001, created on 1 July 2016	(52 pages)
06 Jun 2016	SH20	Statement by Directors	(2 pages)
06 Jun 2016	SH19	Statement of capital on 6 June 2016 USD 0.01	(4 pages)